The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ivanova G.P.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii

Gorobets L.N.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii

Litvinov A.V.

kafedra terapii fakul'teta povysheniia kvalifikatsii i poslediplomnoĭ podgotovki spetsialistov Smolenskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Bulanov V.S.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii Minzdrava Rossii, Moskva

Vasilenko L.M.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii Minzdrava Rossii, Moskva

A role of progesterone and its metabolites in regulation functions of the brain

Authors:

Ivanova G.P., Gorobets L.N., Litvinov A.V., Bulanov V.S., Vasilenko L.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(5): 129‑137

DOI: 10.17116/jnevro201811851129

Read: 27826 times

Download PDF (RU)
Contact the author
Table of contents

A ROLE OF PROGESTERONE AND ITS METABOLITES IN REGULATION FUNCTIONS OF THE BRAIN
A ROLE OF PROGESTERONE AND ITS METABOLITES IN REGULATION FUNCTIONS OF THE BRAIN

To cite this article:

Ivanova GP, Gorobets LN, Litvinov AV, Bulanov VS, Vasilenko LM. A role of progesterone and its metabolites in regulation functions of the brain. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(5):129‑137. (In Russ.)
https://doi.org/10.17116/jnevro201811851129

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Psychopathological diso­rders at the onset of juve­nile parkinsonism in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):96-102
A clinical case of diabulimia in type 1 diabetes mellitus: Psychopathological mechanisms and psychosomatic rela­tionships. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):118-123
Deve­lopment of sele­ctive method for identifying mebe­verine in hair. Fore­nsic Medi­cal Expe­rtise. 2024;(5):29-35
New aspe­cts of psoriasis pathogenesis: meta­bolomic profiling in dermatology. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):526-531
Evaluation of prognostic factors of preterm birth. Russian Journal of Human Reproduction. 2025;(2):37-43
Evaluation of hormonal function of the placenta in pregnant women with geni­tal vari­cose veins. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):73-78
Vari­cose veins in chro­nic expe­riment. Piro­gov Russian Journal of Surgery. 2025;(7):16-23
Abstract:

The review presents literature data reflecting the nature and mechanism of the effect of progesterone and its metabolites on human and animal brain structures. Particular attention is paid to neuroprotective, anticonvulsant, anti-anxiety and sedative properties of this hormone, which determines the prospect of its use for the prevention and treatment of human neurodegenerative diseases, epilepsy, sleep disorders, and anxiety-depressive spectrum disorders, including premenstrual and climacteric syndromes.

Keywords:

progesterone
metabolites
CNS
psychopathology

Authors:

Ivanova G.P.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii

Gorobets L.N.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii

Litvinov A.V.

kafedra terapii fakul'teta povysheniia kvalifikatsii i poslediplomnoĭ podgotovki spetsialistov Smolenskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Bulanov V.S.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii Minzdrava Rossii, Moskva

Vasilenko L.M.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii Minzdrava Rossii, Moskva

Close metadata

References:

  1. McEwen BS, Alves SE, Bulloch K, Weiland NG. Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol Bull. 1998;34:251-259.
  2. Toran-Allerand CD, Singh M, Setalo GJ. Novel mechanisms of estrogen ac-tion in the brain: new players in an old story. Front Neuroendocrinol. 1999;20:97-121. https://doi.org/10.1006/frne.1999.0177
  3. Stoffel О, Wagner B. Neurosteroid metabolism in the human brain. Eur J Endocrinol. 2001;145(6):669-679. https://doi.org/10.1530/eje.0.1450669
  4. Sapronov YuO, Fedotova E.I. Experimental and clinical aspects of psychoneuroendocrinology. V mon.: Osnovy Neiroendokrinologii. SPb.: ELBI; 2005. (In Russ.)
  5. Babichev VN. Neuroendocrine effect of sex hormones. Uspekhi fiziol. nauk. 2005;36(1):54-67. (In Russ.)
  6. Carroll J, Rosario E. The potential use of hor- mone-based therapeutics for the treatment of Alzheimer’s disease. Curr Alzheimer Res. 2012;9(1):18-34. https://doi.org/10.2174/156720512799015109
  7. Garay L, Deniselle MC, Meyer M, Costa JJ, Lima A, Roig P, De Nicola AF. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis. Brain Res. 2009;1283:177-185. https://doi.org/10.1016/j.brainres.2009.04.057
  8. Gargiulo Monachelli G, Meyer M, Rodriguez GE, Garay LI, Sica RE, De Nicola AF, Gonzalez Deniselle MC. Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors. Acta Neurol Scand. 2011;123:60-67. https://doi.org/10.1111/j.1600-0404.2010.01385.x
  9. Frye CA. 3α-hydroxy-5α-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors. Neuroscience. 2006;138:1007-1014. https://doi.org/10.1016/j.neuroscience.2005.06.015
  10. Baulieu E, Schumacher M. Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids. 2000;65(10-11):605-612. https://doi.org/10.1016/s0039-128x(00)00173-2
  11. King TL, Brucker MC. Pharmacology for Women’s Health. Jones & Bartlett Publishers. 2010;372-373.
  12. Khashchenko EP, Uvarova EV. Mechanisms of the effect of progesterone and its derivatives on the central nervous system. Reprodukt zdorov’e detei i podrostkov. 2014;5:68-71. (In Russ.)
  13. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, Garcia-Segura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A, Suter U, Carelli C, Baulieu EE, Akwa Y. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol. 2003;71:3-29. https://doi.org/10.1016/j.pneurobio.2003.09.004
  14. Zwain I, Yen S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology. 1999;140:3843-3852. https://doi.org/10.1210/en.140.8.3843
  15. Shüle C, Eser D, Bachai C. Review: Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience. 2011;191:55-77. https://doi.org/10.1016/j.neuroscience.2011.03.025
  16. Costa E, Auta J, Guidotti A, Korneyev A, Romeo E. The pharmacology of neurosteroidogenesis. J Steroid Biochem Mol Biol. 1994;49:385-389. https://doi.org/10.1016/0960-0760(94)90284-4
  17. Schumacher M, Mattern C. Revisiting the roles of progesterone and allopreg-nanolone in the nervous system: Resurgence of the progesterone receptor. Prog Neurobiol. 2014;113:6-39. https://doi.org/10.1016/j.pneurobio.2013.09.004
  18. Pardridge W, Mietus L. Transport of steroid hor-mones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest. 1979;64:145-154. https://doi.org/10.1172/jci109433
  19. Schumacher M, Hussain R, Gago N. Progesterone synthesis in the nervous system: implications for myelination and myelin repair. Front Neurosci. 2012;6:10-11. https://doi.org/10.3389/fnins.2012.00010
  20. Khodyrev GN, Tsirkin
 VI. The effect of estrogens and progesterone on the functional state of neurons in the brain. Vestnik Nizhegorodskogo universiteta im. N.I. Lobachevskogo. 2012;2(3):295-299. (In Russ.)
  21. Jacobsen BM, Horwitz KB. Progesterone receptors, their isoforms and progesterone regulated transcription. Mol Cell Endocrinol. 2012;357(1-2):18-29. https://doi.org/10.1016/j.mce.2011.09.016
  22. O’Malley BW, Tsai SY, Bagchi M, Weigel NL, Schrader WT, Tsai MJ. Molecular mechanism of action of a steroid hormone receptor. Recent Prog Horm Res. 1991;47:1-26. https://doi.org/10.1016/b978-0-12-571147-0.50005-6
  23. Gonzalez-Flores O, Shu J, Camacho-Arroyo I, Etgen AM. Regulation of lordosis by cyclic 30,50-guanosine monophosphate, progesterone, and its 5alpha-reduced metabolites involves mitogen-activated protein kinase. Endocrinology. 2004;145:5560-5567. https://doi.org/10.1210/en.2004-0823
  24. Hagihara K, Hirata S, Osada T, Hirai M, Kato J. Distribution of cells contain-ing progesterone receptor mRNA in the female rat di- and telencephalon: an in situ hybridiza-tion study. Brain Res Mol Brain Res. 1992;14:239-249. https://doi.org/10.1016/0169-328x(92)90179-f
  25. Gould E, Woolley C, Frankfurt M. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci. 1990;10(4):1286-1291.
  26. Martini M, Pradotto M, Panzica G. Synergic effects of estradiol and progesteroneon regulationof the hypothalamic neuronal nitric oxide synthase expressionin ovariectomized mice. Brain Res. 2011;1404:1-9. https://doi.org/10.1016/j.brainres.2011.06.017
  27. Tang Y, Janssen WG, Hao J, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH, Hof PR, Morrison JH. Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex. 2004;14(2):215-223. https://doi.org/10.1093/cercor/bhg121
  28. Parsons B, Rainbow TC, MacLusky NJ, McEwen BS. Progestin receptor levels in rat hypothalamic and limbic nuclei. J Neurosci. 1982;2:1446-1452.
  29. Sachs M, Pape H, Speckmann E. The effect of estrogen and progesterone on spreading depression in rat neocortical tissues. Neurobiol Dis. 2007;25(1):27-34. https://doi.org/10.1016/j.nbd.2006.08.013
  30. Lopez V, Wagner CK. Progestin receptor is transiently expressed perinatally in neurons of the rat isocortex. J Comp Neurol. 2009;512:124-139. https://doi.org/10.1002/cne.21883
  31. Waters EM, Torres-Reveron A, McEwen BS, Milner TA. Ultrastructural lo-calization of extranuclear progestin receptors in the rat hippocampal formation. J Comp Neurol. 2008;511:34-46. https://doi.org/10.1002/cne.21826
  32. Quadros P, Pfau J, Wagner C. Distribution of progesterone receptor immunoreactivity in the fetal and neonatal rat forebrain. J Comp Neurol. 2007;504(1):42-56. https://doi.org/10.1002/cne.21427
  33. Kawata M, Matsuda K, Nishi M, Ogawa H, Ochiai I. Intracellular dynamics of steroid hormone receptor. Neurosci Res. 2001;40:197-203. https://doi.org/10.1016/s0168-0102(01)00253-x
  34. Tetel M. Nuclear receptor coactivators: essential players for steroid hormone ac-tion in the brain and in behavior. J Neuroendocrinol. 2009;21(4): 229-237. https://doi.org/10.1111/j.1365-2826.2009.01827.x
  35. Thomas P, Pang Y. Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells. Neuroendocrinology. 2012;96(2):162-171. https://doi.org/10.1159/000339822
  36. Morrison J, Hof P. Life and death of neurons in the aging cerebral cortex. Int Rev Neurobiol. 2007;81:41-57. https://doi.org/10.1016/s0074-7742(06)81004-4
  37. Sitruk-Ware R. Pharmacological profile of progestins. Maturitas. 2008;61:151-157. https://doi.org/10.1016/j.maturitas.2008.11.011
  38. Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev. 1990;11:266-301. https://doi.org/10.1210/edrv-11-2-266
  39. Karavolas HJ, Hodges D, O’Brien D. Uptake of (3H)progesterone and (3H)5alpha-dihydroprogesterone by rat tissues in vivo and analysis of accu- mulated radioactivity: accumulation of 5alpha-dihydroprogesterone by pituitary and hypothalamic tissues. Endocrinology. 1976;98:164-175. https://doi.org/10.1210/endo-98-1-164
  40. MacKenzie G. Neurosteroids and GABAergig signaling in health and disease. Biol Mol Conc. 2013;4:29-42. https://doi.org/10.1515/bmc-2012-0033
  41. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986;232:1004-1007. https://doi.org/10.1126/science.2422758
  42. Rupprecht R, Hauser CA, Trapp T, Holsboer F. Neurosteroids: molecular mechanisms of action and psychopharmacological significance. J Steroid Biochem Mol Biol. 1996;56:163-168. https://doi.org/10.1016/0960-0760(95)00233-2
  43. Hosie AM, Wilkins ME, da Silva HM, Smart TG. Endogenous neuroster-oids regulate GABAA receptors through two discrete transmembrane sites. Nature. 2006;444:486-489. https://doi.org/10.1038/nature05324
  44. Belelli D, Lambert JJ. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci. 2005;6:565-575. https://doi.org/10.1038/nrn1703
  45. Reddy DS, O’Malley BW, Rogawski MA. Anxiolytic activity of progester- one in progesterone receptor knockout mice. Neuropharmacology. 2005;4:14-24. https://doi.org/10.1016/j.neuropharm.2004.09.002
  46. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsycho-pharmacologicalproperties. Psychoneuroendocrinology. 2003;28:139-168. https://doi.org/10.1016/s0306-4530(02)00064-1
  47. Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9:971-988. https://doi.org/10.1038/nrd3295
  48. Frye CA. Hormonal influences on seizures: basic neurobiology. Int Rev Neurobiol. 2008;83:27-77. https://doi.org/10.1016/s0074-7742(08)00003-2
  49. Peper JS, van den Heuvel MP, Mandl RC, Hulshoff Pol HE, van Honk J. Steroids and connectivity in the human brain: a review of neuroimaging studies. Psychoneuroendocrinology. 2011;36:1101-1113. https://doi.org/10.1016/j.psyneuen.2011.05.004
  50. Al-Dahan M, Tehrani JM, Thalmann R. Regulation of cyclic AMP level by progesterone in ovariectomized rat neocortex. Brain Res. 1999;824:2:258-266. https://doi.org/10.1016/0006-8993(94)91854-6
  51. Kelley B, Mermelstein P. Progesterone blocks multiple routes of ion flux. Mol Cell Neurosci. 2011;48:2:137-141. https://doi.org/10.1016/j.mcn.2011.07.002
  52. Tsutsui K, Ukena K, Usui M, Sakamoto H, Takase M. Novel brain function: biosynthesis and actions of neurosteroids in neurons. Neurosci Res. 2000;36(4):261-273. https://doi.org/10.1016/s0168-0102(99)00132-7
  53. Finocchi C, Ferrari M. Female reproductive steroids and neuronal excitability. Neurol Sci. 2011;32(suppl 1)31-35. https://doi.org/10.1007/s10072-011-0532-5
  54. Koenig HL, Schumacher M, Ferzaz B, Thi AN, Ressouches A, Guennoun R, Jung-Testas I, Robel P, Akwa Y, Baulieu EE. Progesterone synthesis and myelin formation by Schwann cells. Science. 1995;268:1500-1503. https://doi.org/10.1126/science.7770777
  55. Behl C, Trapp T, Skutella T, Holsboer F. Protection against oxidative stress-induced neuronal cell death: a novel role for RU486. Eur J Neurosci. 1997;9:912-920. https://doi.org/10.1111/j.1460-9568.1997.tb01442.x
  56. Djebaili M, Guo Q, Pettus EH, Hoffman SW, Stein DG. The neurosteroids proges-terone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma. 2005;22:106-118. https://doi.org/10.1089/neu.2005.22.106
  57. Wright DW, Kellermann AL. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007;49:391-402. https://doi.org/10.1016/j.annemergmed.2006.07.932
  58. Asbury ET, Fritts ME, Horton JE, Isaac WL. Progesterone facilitates the acquisi-tion of avoidance learning and protects against subcortical neuronal death following prefrontal cortex ablation in the rat. Behav Brain Res. 1998;97:99-106. https://doi.org/10.1016/s0166-4328(98)00031-x
  59. Kumon Y, Kim SC, Tompkins P, Stevens A, Sakaki S, Loftus CM. Neuroprotec-tive effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J Neurosurg. 2000;92:848-852. https://doi.org/10.3171/jns.2000.92.5.0848
  60. Pettus EH, Wright DW, Stein DG, Hoffman SW. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 2005;1049:112-119. https://doi.org/10.1016/j.psyneuen.2011.05.004
  61. Roof RL, Duvdevani R, Heyburn JW, Stein DG. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol. 1996;138:246-251. https://doi.org/10.1006/exnr.1996.0063
  62. Stein DG. Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev. 2008;57(2):386-397. https://doi.org/10.1016/j.brainresrev.2007.06.012
  63. Stein DG. Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update. Neuroscience. 2011;191:101-116. https://doi.org/10.1016/j.neuroscience.2011.04.013
  64. Herson PS, Koerner IP, Hurn PD Sex, sex steroids, and brain injury. Semin Reprod Med. 2009;27(3):229-239. https://doi.org/10.1055/s-0029-1216276
  65. Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care. 2008;12(2):565-571. https://doi.org/10.1186/cc6887
  66. Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res. 1997;52:1-32.
  67. Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA. 1999;96:13512-13517. https://doi.org/10.1073/pnas.96.23.13512
  68. De Lin’er B. Natural progesterone and its features. Rossiiskii vestnik akushera-ginekologa. 2003;6:27-30. (In Russ.)
  69. Yawno T, Yan EB, Walker DW, Hirst JJ. Inhibition of neurosteroid syn-thesis increases asphyxia-induced brain injury in the late gestation fetal sheep. Neuroscience. 2007;146:1726-1733. https://doi.org/10.1016/j.neuroscience.2007.03.023
  70. Reznikov AG. Progestogens, pregnancy and fetal health. Ginekologiya. 2003;5(6):260-262. (In Russ.)
  71. Baron-Cohen S, Auyeung B, Nørgaard-Pedersen B, Hougaard DM, Abdallah MW, Melgaard L, Cohen AS, Chakrabarti B, Ruta L, Lombardo MV. Elevated fetal steroidogenic activity in autism. Mol Psychiatry. 2015;20(3):369-376. https://doi.org/10.1038/mp.2014.48
  72. Strifert K. The link between oral contraceptive use and prevalence in autism spectrum disorder. Med Hypotheses. 2014;83(6):718-725. https://doi.org/10.1016/j.mehy.2014.09.026
  73. Whitaker-Azmitia PM, Lobel M, Moyer A. Low maternal progesterone may contribute to both obstetrical complications and autism. Med Hypotheses. 2014;82(3):313-318. https://doi.org/10.1016/j.mehy.2013.12.018
  74. Trotter A, Steinmacher J, Kron M, Pohlandt F.Neurodevelopmental follow-up at five years corrected age of extremely low birth weight infants after postnatal replacement of 17β-estradiol and progesterone. J Clin Endocrinol Metab. 2012;97(3):1041-1047. https://doi.org/10.1210/jc.2011-2612
  75. De Nicola AF, Labombarda F, Gonzalez SL, Gonzalez Deniselle MC, Guennoun R, Schumacher M. Steroid effects on glial cells: detrimental or protective for spinal cord injury? Ann NY Acad Sci. 2003;1007:317-328. https://doi.org/10.1196/annals.1286.030
  76. Schumacher M, Guennoun R, Ghoumari A, Massaad C, Robert F, El-Etr M, Akwa Y, Rajkowski K, Baulieu EE. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev. 2007;28(4):387-439. https://doi.org/10.1210/er.2006-0050
  77. Brunton PJ, Russell JA. Allopregnanolone and suppressed hypothalamo — pituitary — adrenal axis stress responses in late pregnancy in the rat. Stress. 2011;14:6-12. https://doi.org/10.3109/10253890.2010.482628
  78. Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci. 2011;13:22-37. https://doi.org/10.1038/nrn3138
  79. Barbaccia ML, Serra M, Purdy RH, Biggio G. Stress and neuroactive steroids. Int Rev Neurobiol. 2001;46:243-272. https://doi.org/10.1016/s0074-7742(01)46065-x
  80. Patchev VK, Almeida OF. Gonadal steroids exert facilitating and buffering effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hor-mone and corticosteroid receptor genes in rat brain. J Neurosci. 1996;16:7077-7084.
  81. McEwen BS, Eiland L, Hunter RG, Miller MM. Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology. 2012;62:3-12. https://doi.org/10.1016/j.neuropharm.2011.07.014
  82. Martin EI, Ressler KJ, Binder E, Nemeroff CB. The neurobiology of anxie-ty disorders: brain imaging, genetics, and psychoneuroendocrinology. Clin Lab Med. 2010;3:865-891. https://doi.org/10.1016/j.cll.2010.07.006
  83. Kalinina TS, Shimshirt AA, Kudryashov NV, Voronina TA, Seredenin SB. Neurosteroidogenesis and exploratory behavior of rodents. Eksperimental’naya i klinicheskaya farmakologiya. 2014;64(2):3-7. (In Russ.)
  84. Bitran D, Foley M, Audette D, Leslie N, Frye CA. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl). 2000;15:64-71. https://doi.org/10.1007/s002130000471
  85. Frye CA, Sumida K, Dudek BC, Harney JP, Lydon JP, O’Malley BW, Pfaff DW, Rhodes ME. Progesterone’s effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology (Berl). 2006;186:312-322. https://doi.org/10.1007/s00213-006-0309-3
  86. Angst J, Sellaro R, Merikangas KR, Endicott J. The epidemiology of peri-menstrual psychological symptoms. Acta Psychiatr Scand. 2001;104:110-116. https://doi.org/10.1034/j.1600-0447.2001.00412.x
  87. Seeman MV. Psychopathology in women and men: Focus on female hormones. Am J Psychiatry. 1997;154:1641-1647. https://doi.org/10.1176/ajp.154.12.1641
  88. Nillni YI, Toufexis DJ, Rohan KJ. Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev. 2011;31(7):1183-1191. https://doi.org/10.1016/j.cpr.2011.07.006
  89. Schiller CE, Schmidt PJ, Rubinow DR. Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology (Berl). 2014;231(17):3557-3567. https://doi.org/10.1007/s00213-014-3599-x
  90. Ganzenko MA, Bairamov AA, Gritsevskaya EM, Mazo GE. The role of progesterone in the formation of depression during the menopausal transition. Psikhicheskoe zdorov’e. 2017;2:85-90. (In Russ.)
  91. Brockington IF, Meakin CJ. Clinical clues to the aetiology of puerperal psychosis. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:417-429. https://doi.org/10.1016/0278-5846(94)90001-9
  92. Harris B, Lovett L, Newcombe RG, Read GF, Walker R, Riad-Fahmy D. Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. BMJ. 1994;308:949-953. https://doi.org/10.1136/bmj.308.6934.949
  93. Girdler SS, Klatzkin R. Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol Ther. 2007;116(1):125-139. https://doi.org/10.1016/j.pharmthera.2007.05.006
  94. Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci USA. 2003;100(4): 2035-2040. https://doi.org/10.1073/pnas.0337642100
  95. Pinna G, Costa E, Guidotti A Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids. Proc Natl Acad Sci USA. 2004;101(16):6222-6225. https://doi.org/10.1073/pnas.0401479101
  96. Zhang LM, Qiu ZK, Chen XF, Zhao N, Chen HX, Xue R, Zhang YZ, Yang RF, Li YF. Involvement of allopregnanolone in the anti-PTSD-like effects of AC-5216. J Psychopharmacol. 2016;30(5):474-481. https://doi.org/10.1177/0269881115625115
  97. Bitran D, Klibansky DA, Martin GA. The neurosteroid pregnanolone prevents the anxiogeniclike effect of inescapable shock in the rat. Psychopharmacology (Berl). 2000;151:31-37. https://doi.org/10.1007/s002130000472
  98. Santoru F, Berretti R, Locci A, Porcu P, Concas A. Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats. Psychopharmacology (Berl). 2014;231(17):3351-3364. https://doi.org/10.1007/s00213-014-3539-9
  99. Uphouse L. Dose-dependent effects of the antiprogestin, RU486, on sexual behavior of naturally cycling Fischer rats. Behav Brain Res. 2015;1:282:95-102. https://doi.org/10.1016/j.bbr.2015.01.004
  100. O’Connell LA, Matthews BJ, Crews D. Neuronal nitric oxide synthase as a substrate for the evolution of pseudosexual behaviour in a parthenogenetic whiptail lizard. J Neuroendocrinol. 2011;23(3):244-253. https://doi.org/10.1111/j.1365-2826.2010.02099.x
  101. Engel SR, Purdy RH, Grant KA. Characterization of discriminative stimulus effects of the neuroactive steroid pregnenolone. J Pharmacol Exp Ther. 2001;297:489-495.
  102. Merryman W, Boiman R, Barnes L, Rothschild I. Progesterone «anaesthesia» in human subjects. J Clin Endocrinol Metab. 1954;14:1567-1569. https://doi.org/10.1210/jcem-14-12-1567
  103. Backstrom Т, Zettelung В, Blom S, Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand. 1984;69:240-248. https://doi.org/10.1111/j.1600-0404.1984.tb07807.x
  104. Kryzhanovskii GN, Glebov RN. Hormones and epileptic activity. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 1984;84(6):930-937. (In Russ.)
  105. Beals KA, Brey RA, Gonyou JB. Understanding the femaleathlete triad: eating disorders, amenorrhea, and osteoporosis. J Sch Health. 1999;69:8: 337-340. https://doi.org/10.1111/j.1746-1561.1999.tb06425.x
  106. Bitran D, Purdy RH, Kellogg CK. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAa receptor function. Pharmacol Biochem Behav. 1993;45:423-428. https://doi.org/10.1016/0091-3057(93)90260-z
  107. Reddy DS, Kulkami SK. Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyper-activity in mice. Methods Find Exp Clin Pharmacol. 1997;19:395-405.
  108. Singh A, Kumar A. Possible GABAergic modulation in the protective effect of allopregnanolone on sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Methods Find Exp Clin Pharmacol. 2008;30(9):681-689. https://doi.org/10.1358/mf.2008.30.9.1323493
  109. Terán-Pérez G, Arana-Lechuga Y, Esqueda-León E, Santana-Miranda R, Ro-jas-Zamorano JÁ, Velázquez Moctezuma J. Steroid hormones and sleep regulation. Mini Rev Med Chem. 2012;12(11):1040-1048. https://doi.org/10.2174/138955712802762167
  110. Kerrigan JF, Shields WD, Nelson TY, Bluestone DL, Dodson WE, Bourgeois BF, Pellock JM, Morton LD, Monaghan EP. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res. 2000;42:133-139. https://doi.org/10.1016/s0920-1211(00)00170-4
  111. Patil CY, Jadhav SA, Doifode SM, Baig MS. Neuroactive steroids and their role in epilepsy. International Journal Basic Clinical Pharmacology. 2012;1(suppl 3):150-159. https://doi.org/10.5455/2319-2003.ijbcp004212
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.